If you wish to apply to be lead plaintiff, please contact attorney Nicholas Bruno at (888) 398-9312 or at [email protected].

TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...

New York, New York-- (Newsfile Corp. - March 13, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...

Outside of the U.S., where OrganOx has a larger footprint, livers account for about 1% of TransMedics Group's sales. If ...

NasdaqGM:TMDX Earnings and Revenue History March 7th 2025 A Closer Look At TransMedics Group's Earnings. One key financial ratio used to measure how well a company converts its pr ...

SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ ...

It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August. The company's warm perfusion ...

Equities research analysts at William Blair raised their Q3 2025 earnings estimates for shares of TransMedics Group in a ...

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate ...

BNY Mellon Small Cap Growth Fund outperformed its benchmark, the Russell 2000 Growth Index during Q4 2024. Click here to read ...